GlassScriptPhysician profile
Randall N Goodroe
NPI 1730271602
$5,171.37
in general payments reported to CMS, 2019-2025
26 companies · $1,001 in 2025
The $1,001 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $420 · 2021: $628 · 2022: $509 · 2023: $1,113 · 2024: $1,170 · 2025: $1,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,794 · Travel and Lodging: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,793.89 |
| Travel and Lodging | $489.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,317.52 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Rotablator Rotational Atherectomy System Console Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $843.80 | 2019-2025 | Lifevest |
| Heartflow, INC. | $671.34 | 2023 | Ffrct |
| Shockwave Medical, INC | $423.42 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $412.65 | 2024-2025 | Impella |
| Abbott Laboratories | $212.91 | 2021-2023 | Aveir, Xience Sierra |
| Recor Medical INC | $161.02 | 2025 | Paradise Ultrasound Renal Denervation System |
| Medtronic, INC. | $145.87 | 2025 | Symplicity G3 |
| Cardiovascular Systems INC. | $141.01 | 2023 | Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $139.57 | 2023-2025 | |
| W. L. Gore & Associates, INC. | $106.02 | 2020 | |
| Edwards Lifesciences Corporation | $91.17 | 2020-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $83.68 | 2023-2025 | |
| Atricure, INC. | $73.50 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Amgen INC. | $55.73 | 2022-2025 | Repatha, Repatha |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $55.38 | 2020-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| E.R. Squibb & Sons, L.L.C. | $42.63 | 2024-2025 | Eliquis, Camzyos |
| Kiniksa Pharmaceuticals International, Plc | $38.27 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $32.42 | 2025 | |
| Novo Nordisk INC | $23.80 | 2024 | Wegovy |
| Sanofi-Aventis U.S. LLC | $20.10 | 2024 | |
| Irhythm Technologies, INC. | $19.95 | 2024 | Zio Xt Patch |
| Cordis US Corp. | $18.19 | 2025 | Mynx Control Venous |
| Terumo Medical Corporation | $15.51 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.44 | 2024 | Xarelto |
| Medtronic Vascular, INC. | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Goodroe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.